PropertyValue
?:abstract
  • INTRODUCTION: The safety of upper gastrointestinal cancer patients in the SARS-CoV-2 outbreak is extremely important and most surgeons need to establish a contingency management AIM: In this study, we present the surgical outlines of patients suffering from upper gastrointestinal cancers MATERIALS AND METHODS: Data were obtained from PubMed, Cochrane Database of Controlled Trials, and SCOPUS of reports up to September 2020 RESULTS: The COVID-19 outbreak makes surgical procedures extremely difficult to be performed The most common criteria to prioritize patients for surgical treatment are stage, tumor biology, presence of tumor-related symptoms, the risk of tumor to become non-resectable, and time interval from neoadjuvant therapy The multidisciplinary teams can help assigning a priority level to each clinical case CONCLUSION: We have to continue providing treatment to oncologic patients in the face of COVID-19 uncertainty, with higher caution and responsibility in order to develop a safer and more effective personalized treatment plan
is ?:annotates of
?:creator
?:journal
  • J_Gastrointest_Cancer
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations
?:type
?:who_covidence_id
  • #947062
?:year
  • 2020

Metadata

Anon_0  
expand all